SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion.
Leuzzi G, Vasciaveo A, Taglialatela A, Chen X, Firestone TM, Hickman AR, Mao W, Thakar T, Vaitsiankova A, Huang JW, Cuella-Martin R, Hayward SB, Kesner JS, Ghasemzadeh A, Nambiar TS, Ho P, Rialdi A, Hebrard M, Li Y, Gao J, Gopinath S, Adeleke OA, Venters BJ, Drake CG, Baer R, Izar B, Guccione E, Keogh MC, Guerois R, Sun L, Lu C, Califano A, Ciccia A
Cell 2024 Feb 15 ;187(4):861-881.e32Subtype-selective prenylated isoflavonoids disrupt regulatory drivers of MYCN-amplified cancers.
Stokes ME, Vasciaveo A, Small JC, Zask A, Reznik E, Smith N, Wang Q, Daniels J, Forouhar F, Rajbhandari P, Califano A, Stockwell BR
Cell Chem Biol 2024 Apr 18 ;31(4):805-819.e9OncoLoop: A Network-Based Precision Cancer Medicine Framework.
Vasciaveo A, Arriaga JM, de Almeida FN, Zou M, Douglass EF, Picech F, Shibata M, Rodriguez-Calero A, de Brot S, Mitrofanova A, Chua CW, Karan C, Realubit R, Pampou S, Kim JY, Afari SN, Mukhammadov T, Zanella L, Corey E, Alvarez MJ, Rubin MA, Shen MM, Califano A, Abate-Shen C
Cancer Discov 2023 Feb 6 ;13(2):386-409Mesenchymal subtype neuroblastomas are addicted to TGF-βR2/HMGCR-driven protein geranylgeranylation.
Stokes ME, Small JC, Vasciaveo A, Shimada K, Hirschhorn T, Califano A, Stockwell BR
Sci Rep 2020 Jul 1 ;10(1):10748Engineering of human cardiac muscle electromechanically matured to an adult-like phenotype.
Ronaldson-Bouchard K, Yeager K, Teles D, Chen T, Ma S, Song L, Morikawa K, Wobma HM, Vasciaveo A, Ruiz EC, Yazawa M, Vunjak-Novakovic G
Nat Protoc 2019 Oct ;14(10):2781-2817Common integration sites of published datasets identified using a graph-based framework.
Vasciaveo A, Velevska I, Politano G, Savino A, Schmidt M, Fronza R
Comput Struct Biotechnol J 2016 ;14():87-90An extended gene protein/products Boolean network model including post-transcriptional regulation.
Benso A, Di Carlo S, Politano G, Savino A, Vasciaveo A
Theor Biol Med Model 2014 May 7 ;11 Suppl 1(Suppl 1):S5